Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishenshumian is a Traditional Chinese Medicine (TCM) granule formulation developed by the Shanghai Traditional Chinese Medicine Hospital for the treatment of chronic insomnia. The formulation is based on the 'sleep balance method' (睡眠平衡法), a TCM therapeutic approach that focuses on harmonizing the body's internal state to promote natural sleep patterns. It is currently being evaluated in clinical trials (e.g., ChiCTR2000036022) to verify its clinical efficacy and safety, with the goal of expanding its application as a therapeutic option for patients suffering from persistent sleep disturbances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yishenshumian.